These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

678 related articles for article (PubMed ID: 38136750)

  • 21. New insights into the resistance mechanism for the BceAB-type transporter SaNsrFP.
    Gottstein J; Zaschke-Kriesche J; Unsleber S; Voitsekhovskaia I; Kulik A; Behrmann LV; Overbeck N; Stühler K; Stegmann E; Smits SHJ
    Sci Rep; 2022 Mar; 12(1):4232. PubMed ID: 35273305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular mechanisms of membrane perturbation by antimicrobial peptides and the use of biophysical studies in the design of novel peptide antibiotics.
    Lohner K; Blondelle SE
    Comb Chem High Throughput Screen; 2005 May; 8(3):241-56. PubMed ID: 15892626
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nanotechnology as a Novel Approach in Combating Microbes Providing an Alternative to Antibiotics.
    Mubeen B; Ansar AN; Rasool R; Ullah I; Imam SS; Alshehri S; Ghoneim MM; Alzarea SI; Nadeem MS; Kazmi I
    Antibiotics (Basel); 2021 Nov; 10(12):. PubMed ID: 34943685
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibiotic Resistance: Challenges and Strategies in Combating Infections.
    Chavada J; Muneshwar KN; Ghulaxe Y; Wani M; Sarda PP; Huse S
    Cureus; 2023 Sep; 15(9):e46013. PubMed ID: 37900415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Role of Antibiotic-Target-Modifying and Antibiotic-Modifying Enzymes in
    Luthra S; Rominski A; Sander P
    Front Microbiol; 2018; 9():2179. PubMed ID: 30258428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Solanimycin: Biosynthesis and Distribution of a New Antifungal Antibiotic Regulated by Two Quorum-Sensing Systems.
    Matilla MA; Monson RE; Murphy A; Schicketanz M; Rawlinson A; Duncan C; Mata J; Leeper F; Salmond GPC
    mBio; 2022 Dec; 13(6):e0247222. PubMed ID: 36214559
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance.
    Ghannoum MA; Rice LB
    Clin Microbiol Rev; 1999 Oct; 12(4):501-17. PubMed ID: 10515900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peptides Affecting the Outer Membrane Lipid Asymmetry System (MlaA-OmpC/F) Reduce Avian Pathogenic Escherichia coli (APEC) Colonization in Chickens.
    Kathayat D; Closs G; Helmy YA; Lokesh D; Ranjit S; Rajashekara G
    Appl Environ Microbiol; 2021 Aug; 87(17):e0056721. PubMed ID: 34132592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics and pharmacodynamics of antibacterials, antifungals, and antivirals used most frequently in neonates and infants.
    Roberts JK; Stockmann C; Constance JE; Stiers J; Spigarelli MG; Ward RM; Sherwin CM
    Clin Pharmacokinet; 2014 Jul; 53(7):581-610. PubMed ID: 24871768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospects of Exploring the Metal-Organic Framework for Combating Antimicrobial Resistance.
    Polash SA; Khare T; Kumar V; Shukla R
    ACS Appl Bio Mater; 2021 Dec; 4(12):8060-8079. PubMed ID: 35005933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A broad-spectrum synthetic antibiotic that does not evoke bacterial resistance.
    Heithoff DM; Mahan SP; Barnes V L; Leyn SA; George CX; Zlamal JE; Limwongyut J; Bazan GC; Fried JC; Fitzgibbons LN; House JK; Samuel CE; Osterman AL; Low DA; Mahan MJ
    EBioMedicine; 2023 Mar; 89():104461. PubMed ID: 36801104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antimicrobial Peptides Therapy: An Emerging Alternative for Treating Drug-Resistant Bacteria.
    Mba IE; Nweze EI
    Yale J Biol Med; 2022 Dec; 95(4):445-463. PubMed ID: 36568838
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ion Channels Induced by Antimicrobial Agents in Model Lipid Membranes are Modulated by Plant Polyphenols Through Surrounding Lipid Media.
    Efimova SS; Zakharova AA; Medvedev RY; Ostroumova OS
    J Membr Biol; 2018 Aug; 251(4):551-562. PubMed ID: 29549386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular mechanisms of pore formation and membrane disruption by the antimicrobial lantibiotic peptide Mutacin 1140.
    Pokhrel R; Bhattarai N; Baral P; Gerstman BS; Park JH; Handfield M; Chapagain PP
    Phys Chem Chem Phys; 2019 Jun; 21(23):12530-12539. PubMed ID: 31147666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synergistic interactions of phytochemicals with antimicrobial agents: Potential strategy to counteract drug resistance.
    Ayaz M; Ullah F; Sadiq A; Ullah F; Ovais M; Ahmed J; Devkota HP
    Chem Biol Interact; 2019 Aug; 308():294-303. PubMed ID: 31158333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Engineered endolysin-based "Artilysins" to combat multidrug-resistant gram-negative pathogens.
    Briers Y; Walmagh M; Van Puyenbroeck V; Cornelissen A; Cenens W; Aertsen A; Oliveira H; Azeredo J; Verween G; Pirnay JP; Miller S; Volckaert G; Lavigne R
    mBio; 2014 Jul; 5(4):e01379-14. PubMed ID: 24987094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanical properties that influence antimicrobial peptide activity in lipid membranes.
    Marín-Medina N; Ramírez DA; Trier S; Leidy C
    Appl Microbiol Biotechnol; 2016 Dec; 100(24):10251-10263. PubMed ID: 27837316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Killing Mechanism of Teixobactin against Methicillin-Resistant Staphylococcus aureus: an Untargeted Metabolomics Study.
    Hussein M; Karas JA; Schneider-Futschik EK; Chen F; Swarbrick J; Paulin OKA; Hoyer D; Baker M; Zhu Y; Li J; Velkov T
    mSystems; 2020 May; 5(3):. PubMed ID: 32457238
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.